The Bracco Group, a world leader in diagnostic imaging, starts operating directly on the Japanese market from this month. The newborn Bracco Japan has gradually taken the place of Bracco Eisai, the joint venture founded in 1990 and which has undergone two renewals. “Our collaboration has been a long journey together that has brought great results – he wrote Diana BraccoPresident and CEO of the Bracco Group, in a letter to the President of Eisai Haruo Naito – A journey during which we wisely respected the distinct cultures of our two countries.” The announcement on the occasion of an event held at the Italian Embassy in Tokyo in the presence of the Ambassador Gianluigi Benedettiduring the celebrations of the National Made in Italy Week.
Japan and Italy indeed share a long history of friendship and mutual respect. “Today we are honored to strengthen these ties by operating directly with our new, completely autonomous company – he says Fulvio Renoldi Bracco, Vice President and CEO of Bracco Imaging – Japan represents a strategic market for us, both for the high average age of the population and for the widespread culture of prevention present throughout the country and supported by a very advanced healthcare system, particularly in field of diagnostic imaging. A market that will grow very rapidly as will that of the entire Asia-Pacific region. Bracco Japan intends to strengthen our historic presence to better satisfy the needs of local doctors and patients by providing increasingly cutting-edge contrast media, technologies and diagnostic imaging services, integrating our offer with injectors and other products from our ACIST Japan”.
With the completion of the transfer of Bracco Eisai's activities to the new company Bracco Japan – reports a note – which is led by Tetsuaki Sakamoto, now begins a new independent path both as a manufacturer and as a distributor of contrast media. “Our work, however, will not be limited to this – concludes Fulvio Renoldi Bracco – As per tradition, our company's commitment will go beyond commercial activities: we are in fact committed to promoting medical innovation in Japan, with numerous new products in the pipeline of development, and we will be increasingly close to the Japanese radiology community, to listen to its needs and to face the health challenges of tomorrow together”.
#Italy #diagnostic #imaging #Bracco #Japan39s #activity #begins